The RTTN gene is important in early development, especially for cell division and normal brain growth before birth. The protein made by this gene helps your cells organize the structures needed to grow and divide in an orderly way. When both copies of the RTTN gene do not work properly, a child may be born with a smaller head size, differences in brain formation, developmental delay, and sometimes seizures or movement problems. Some people also have slower growth or short stature.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing activities in the body. Some genes carry the information needed to make proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
RTTNGene function
What if the gene works
The RTTN gene helps cells build and organize centrioles, which guide normal cell division and support cilia, the tiny hairlike structures on cells. This is especially important during early brain growth.
Risk
What if the gene does not work
More disruptive variants in the RTTN gene can impair early brain growth, leading to microcephaly, developmental delay, and sometimes seizures or movement differences. Milder variants may lead to a broader range of severity and brain structure changes.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the RTTN gene, no RTTN-specific treatment or drug-selection approach is currently established; care is guided by the person’s symptoms and clinical needs rather than the gene change itself.
Conditions associated with RTTN
Gene function
What if the gene works
Your cells need the RTTN gene to build tiny organizing centers called centrioles. These structures help cells divide in an orderly way and also support cilia, the small hairlike projections found on some cells. Understanding how the RTTN gene works helps explain how cells keep their internal layout steady from one cell cycle to the next.
The RTTN gene helps cells build and shape centrioles, the tiny structures that organize parts of the cell. These small hubs give cells a stable center for growth and for later steps in cell division.
During cell division, the RTTN gene supports the setup of the machinery that separates chromosomes into new cells. This helps each new cell receive the right genetic package in an orderly way.
Centrioles also serve as the base for cilia, which are tiny hairlike projections on some cells. By supporting centriole formation, the RTTN gene also helps cells make cilia that sense signals or move fluid across tissue surfaces.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and contribute to normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply reflect natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RTTN gene can affect protein function by changing how the rotatin protein is built, where it goes in the cell, or how stable it is. Many pathogenic changes disrupt centriole and cilia formation, which can interfere with cell division during early development. Milder variants may leave partial protein activity, while more severe changes, such as protein-shortening variants, often cause a larger loss of function and can be linked to earlier or more marked developmental effects.
How variants are linked to conditions
Among the health conditions linked to RTTN gene variants, the main one is a rare inherited condition often called microcephaly, short stature, and polymicrogyria, with or without seizures. People with a disease-causing variant may have a smaller than expected head size, slower growth, developmental delay, and brain changes seen on scans. Some also have seizures.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not have a direct effect on health. They are simply part of natural human diversity. For many genes, carrying a variant tied to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RTTN gene. In families with a known RTTN change, risk is shaped mainly by whether a child inherits changed copies from both parents, so a doctor or genetic counselor can help explain personal and family risk.
Inheritance of RTTN variants
RTTN-related conditions are usually inherited in an autosomal recessive pattern. This means a child inherits one RTTN gene variant from each parent, and the parents are often healthy carriers with one working copy and one changed copy. When both parents carry a variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how RTTN gene variants are inherited usually involves the same variant pattern passing silently through a family until a child receives both changed copies.
What does my RTTN result mean for my family?
For families with a disease-causing RTTN result tied to a known condition, the pattern is usually recessive, which often means parents are healthy carriers and brothers or sisters could also be carriers or, in some cases, also be affected. Close relatives may want to learn whether the same family change is present, especially when there is a history of similar findings in a child. The meaning for each relative depends on the exact RTTN result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
RTTN genetic testing uses a blood or saliva sample to look for variants in the RTTN gene. The lab reads the gene, often as part of a larger panel or exome test, and compares the result with known disease linked variants. Results may confirm a diagnosis, remain uncertain, or find no relevant variant.
When should I consider getting a genetic test?
Genetic testing for the RTTN gene may be considered when a baby or child has a much smaller-than-expected head size, delayed development, seizures, or brain changes seen on a scan, especially if similar findings run in the family. It can also help explain unusual brain growth seen on prenatal ultrasound.
A genetic result is only one part of your health story
A genetic result can give useful insight, but how much it explains varies based on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. By looking at connections between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the RTTN gene
When should I seek medical advice?
There is no broadly confirmed evidence that changes in this gene affect how medicines work, so general health concerns or questions about treatment and side effects are best discussed with your doctor.
History
The RTTN gene entered the medical literature through research on early development, when scientists were mapping genes that help shape the growing embryo. In the 2000s, researchers began exploring how this gene works in cell division and brain development. Building on this early work, scientists later connected harmful variants in the RTTN gene with inherited conditions affecting head growth and brain formation. These findings came from families whose children shared similar developmental features, which helped confirm the gene’s clinical importance. Over time, descriptions became more precise as genetic sequencing improved and doctors could link RTTN gene variants to a broader range of developmental findings. Today, the RTTN gene is mainly recognized in specialist genetics and pediatric neurology rather than in public awareness.